These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6491300)

  • 21. Isolation and characterization of two toxins from the venom of the Malayan cobra (Naja naja sputatrix).
    Tan NH
    Toxicon; 1983; 21(2):201-7. PubMed ID: 6857705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and characterization of a lethal protein with phospholipase A1 activity from the hornet (Vespa basalis) venom.
    Ho CL; Ko JL
    Biochim Biophys Acta; 1988 Dec; 963(3):414-22. PubMed ID: 3196744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Naja n. naja and Naja h. haje cobra-venom factors: correlation between binding affinity for the fifth component of complement and mediation of its cleavage.
    von Zabern I; Hinsch B; Przyklenk H; Schmidt G; Vogt W
    Immunobiology; 1980 Dec; 157(4-5):499-514. PubMed ID: 6905795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple fractionation of phospholipase A2 analogues from snake venom by high-performance liquid chromatography.
    Lo CH; Chiou SH
    J Chromatogr; 1990 Aug; 530(1):129-36. PubMed ID: 2277102
    [No Abstract]   [Full Text] [Related]  

  • 25. Purification, some properties of two phospholipases A2 (CM-I and CM-II) and the amino-acid sequence of CM-II from Aspidelaps scutatus (shield or shield-nose) venom.
    Joubert FJ
    Biol Chem Hoppe Seyler; 1987 Dec; 368(12):1597-602. PubMed ID: 3442602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular cloning and characterization of a complement-depleting factor from king cobra, Ophiophagus hannah.
    Zeng L; Sun QY; Jin Y; Zhang Y; Lee WH; Zhang Y
    Toxicon; 2012 Sep; 60(3):290-301. PubMed ID: 22561424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of an acidic lethal phospholipase Az from Malayan cobra (Naja naja sputatrix) venom.
    Tan NH; Arunmozhiarasi A
    Biochem Int; 1989 Apr; 18(4):785-92. PubMed ID: 2764979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiotoxins from the venom of Malayan cobra (Naja naja sputatrix).
    Tan NH
    Arch Biochem Biophys; 1982 Oct; 218(1):51-8. PubMed ID: 7149742
    [No Abstract]   [Full Text] [Related]  

  • 29. Phospholipase A2 from Naja naja sputatrix venom is a muscarinic acetylcholine receptor inhibitor.
    Miyoshi S; Tu AT
    Arch Biochem Biophys; 1996 Apr; 328(1):17-25. PubMed ID: 8638927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of a novel phospholipase A2 from king cobra (Ophiophagus hannah) venom.
    Chiou JY; Chang LS; Chen LN; Chang CC
    J Protein Chem; 1995 Aug; 14(6):451-6. PubMed ID: 8593185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino acid sequence and circular dichroism of Indian cobra (Naja naja naja) venom acidic phospholipase A2.
    Davidson FF; Dennis EA
    Biochim Biophys Acta; 1990 Jan; 1037(1):7-15. PubMed ID: 2294972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomics analysis to compare the venom composition between Naja naja and Naja kaouthia from the same geographical location of eastern India: Correlation with pathophysiology of envenomation and immunological cross-reactivity towards commercial polyantivenom.
    Chanda A; Patra A; Kalita B; Mukherjee AK
    Expert Rev Proteomics; 2018 Nov; 15(11):949-961. PubMed ID: 30345852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural studies on the cobra venom factor: isolation, purification, crystallization and preliminary crystallographic analysis.
    Sharma S; Jabeen T; Singh RK; Bredhorst R; Vogel CW; Betzel C; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):596-8. PubMed ID: 11264593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic relationships between human and cobra complement factors C3 and cobra venom factor (CVF) from the Indian cobra (Naja naja).
    Eggertsen G; Lundwall A; Hellman U; Sjöquist J
    J Immunol; 1983 Oct; 131(4):1920-3. PubMed ID: 6194220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of an anticoagulant phospholipase A(2) from Indian monocled cobra (Naja kaouthia) venom.
    Doley R; Mukherjee AK
    Toxicon; 2003 Jan; 41(1):81-91. PubMed ID: 12467665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of the complement activating protein in the venom of the Indian cobra (Naja N. siamensis).
    Eggertsen G; Lind P; Sjöquist J
    Mol Immunol; 1981 Feb; 18(2):125-33. PubMed ID: 6790937
    [No Abstract]   [Full Text] [Related]  

  • 37. An improved method for the isolation from Naja naja venom of cobra factor (CoF) free of phospholipase A.
    Pepys MB; Tompkins C; Smith AD
    J Immunol Methods; 1979; 30(2):105-17. PubMed ID: 574149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical modification of lysine and histidine residues in phospholipase A2 from the venom of Naja naja atra (Taiwan cobra).
    Yang CC; King K; Sun TP
    Toxicon; 1981; 19(5):645-59. PubMed ID: 6795761
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of catalytic function in the antiplatelet activity of phospholipase A2 cobra (Naja naja naja) venom.
    Rudrammaji LM; Machiah KD; Kantha TP; Gowda TV
    Mol Cell Biochem; 2001 Mar; 219(1-2):39-44. PubMed ID: 11354251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical composition, lethality and pathophysiology of venom from two cobras-- Naja naja and N. kaouthia.
    Mukherjee AK; Maity CR
    Comp Biochem Physiol B Biochem Mol Biol; 2002 Feb; 131(2):125-32. PubMed ID: 11818235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.